Entapro is a medication classified as an angiotensin receptor blocker (ARB). It works by selectively blocking angiotensin II receptors, leading to vasodilation and reduced secretion of aldosterone. This action results in decreased blood pressure and improved blood flow to the heart. Entapro is indicated for the treatment of hypertension, heart failure, and diabetic nephropathy. Clinical studies have shown that Entapro effectively lowers blood pressure, reduces the risk of cardiovascular events, and slows the progression of kidney disease in diabetic patients. It is well-tolerated with a low incidence of side effects such as dizziness and hyperkalemia. Entapro plays a crucial role in managing hypertension and associated complications, improving patient outcomes, and enhancing overall cardiovascular health.